A. Louis Bourgeois

6.1k total citations
122 papers, 4.4k citations indexed

About

A. Louis Bourgeois is a scholar working on Infectious Diseases, Endocrinology and Food Science. According to data from OpenAlex, A. Louis Bourgeois has authored 122 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Infectious Diseases, 72 papers in Endocrinology and 25 papers in Food Science. Recurrent topics in A. Louis Bourgeois's work include Viral gastroenteritis research and epidemiology (79 papers), Escherichia coli research studies (70 papers) and Clostridium difficile and Clostridium perfringens research (25 papers). A. Louis Bourgeois is often cited by papers focused on Viral gastroenteritis research and epidemiology (79 papers), Escherichia coli research studies (70 papers) and Clostridium difficile and Clostridium perfringens research (25 papers). A. Louis Bourgeois collaborates with scholars based in United States, Peru and Egypt. A. Louis Bourgeois's co-authors include Richard I. Walker, David A. Sack, Shahida Baqar, Patricia Guerry, Thomas F. Wierzba, Barbara DeNearing, Robin McKenzie, Kenneth C. Hyams, James G. Olson and Thomas E. Hickey and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Microbiology Reviews.

In The Last Decade

A. Louis Bourgeois

120 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Louis Bourgeois United States	42	2.8k	2.0k	1.3k	624	428	122	4.4k
John D. Klena United States	42	2.4k 0.9×	1.6k 0.8×	1.8k 1.4×	461 0.7×	597 1.4×	189	6.1k
James P. Nataro United States	37	2.3k 0.8×	2.2k 1.1×	928 0.7×	333 0.5×	254 0.6×	81	4.7k
C. A. Hart United Kingdom	37	1.5k 0.5×	922 0.5×	1.3k 1.0×	422 0.7×	276 0.6×	132	4.7k
Pablo Vial Chile	32	2.7k 1.0×	1.5k 0.8×	486 0.4×	362 0.6×	175 0.4×	121	4.0k
P Echeverria Thailand	53	3.9k 1.4×	4.1k 2.1×	2.5k 2.0×	1.1k 1.7×	873 2.0×	212	8.4k
Goutam K. Adak United Kingdom	31	2.3k 0.8×	1.6k 0.8×	2.0k 1.6×	167 0.3×	173 0.4×	59	4.1k
Anu Kantele Finland	36	1.8k 0.6×	725 0.4×	602 0.5×	1.2k 1.9×	853 2.0×	160	4.5k
M. M. Levine United States	34	2.5k 0.9×	3.6k 1.8×	1.5k 1.2×	174 0.3×	922 2.2×	56	5.3k
David N. Taylor United States	55	3.9k 1.4×	3.2k 1.6×	2.1k 1.7×	1.1k 1.7×	1.6k 3.7×	183	8.7k
Ladaporn Bodhidatta Thailand	27	1.6k 0.6×	671 0.3×	894 0.7×	317 0.5×	176 0.4×	83	2.7k

Countries citing papers authored by A. Louis Bourgeois

Since Specialization

Citations

This map shows the geographic impact of A. Louis Bourgeois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Louis Bourgeois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Louis Bourgeois more than expected).

Fields of papers citing papers by A. Louis Bourgeois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Louis Bourgeois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Louis Bourgeois. The network helps show where A. Louis Bourgeois may publish in the future.

Co-authorship network of co-authors of A. Louis Bourgeois

This figure shows the co-authorship network connecting the top 25 collaborators of A. Louis Bourgeois. A scholar is included among the top collaborators of A. Louis Bourgeois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Louis Bourgeois. A. Louis Bourgeois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pasetti, Marcela F., Jessica A. White, Rebecca C. Brady, et al.. (2025). Safety and immunogenicity in humans of enterotoxigenic Escherichia coli double mutant heat-labile toxin administered intradermally. npj Vaccines. 10(1). 23–23. 2 indexed citations

Maier, Nicole, Shannon Grahek, Jane L. Halpern, et al.. (2023). Efficacy of an Enterotoxigenic Escherichia coli (ETEC) Vaccine on the Incidence and Severity of Traveler’s Diarrhea (TD): Evaluation of Alternative Endpoints and a TD Severity Score. Microorganisms. 11(10). 2414–2414. 5 indexed citations

Gutiérrez, Ramiro L., Milton Maciel, S. Poole, et al.. (2021). Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli. Vaccine. 39(39). 5548–5556. 27 indexed citations

Clarkson, Kristen A., Chad K. Porter, Kawsar R. Talaat, et al.. (2021). Shigella -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei. mSphere. 6(4). e0012221–e0012221. 11 indexed citations

Clarkson, Kristen A., Chad K. Porter, Kawsar R. Talaat, et al.. (2021). Shigella-Controlled Human Infection Models: Current and Future Perspectives. Current topics in microbiology and immunology. 445. 257–313. 3 indexed citations

Brubaker, Jessica, Xueyan Zhang, A. Louis Bourgeois, et al.. (2021). Intestinal and systemic inflammation induced by symptomatic and asymptomatic enterotoxigenic E. coli infection and impact on intestinal colonization and ETEC specific immune responses in an experimental human challenge model. Gut Microbes. 13(1). 1–13. 42 indexed citations

Clarkson, Kristen A., Robert W. Frenck, Michelle Dickey, et al.. (2020). Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G. mSphere. 5(5). 29 indexed citations

MacLennan, Calman A., Mark S. Riddle, Wilbur H. Chen, et al.. (2019). Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints. Clinical Infectious Diseases. 69(Supplement_8). S591–S595. 23 indexed citations

Talaat, Kawsar R., A. Louis Bourgeois, Robert W. Frenck, et al.. (2019). Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies. Clinical Infectious Diseases. 69(Supplement_8). S580–S590. 26 indexed citations

10.

Kaminski, Robert W., Marcela F. Pasetti, Kristen A. Clarkson, et al.. (2019). Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays. Clinical Infectious Diseases. 69(Supplement_8). S596–S601. 21 indexed citations

11.

Chakraborty, Subhra, Arlo Randall, Tim J. Vickers, et al.. (2019). Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection. npj Vaccines. 4(1). 37–37. 26 indexed citations

12.

Qadri, Firdausi, Marjahan Akhtar, Taufiqur Rahman Bhuiyan, et al.. (2019). Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial. The Lancet Infectious Diseases. 20(2). 208–219. 88 indexed citations

13.

Maciel, Milton, Mark A. Smith, S. Poole, et al.. (2019). Evaluation of the reactogenicity, adjuvanticity and antigenicity of LT(R192G) and LT(R192G/L211A) by intradermal immunization in mice. PLoS ONE. 14(11). e0224073–e0224073. 16 indexed citations

14.

Savarino, Stephen J., Robin McKenzie, David R. Tribble, et al.. (2017). Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial. The Journal of Infectious Diseases. 216(1). 7–13. 43 indexed citations

15.

McKenzie, R., Chad K. Porter, Joyce A. Cantrell, et al.. (2011). Volunteer Challenge With Enterotoxigenic Escherichia coli That Express Intestinal Colonization Factor Fimbriae CS17 and CS19. The Journal of Infectious Diseases. 204(1). 60–64. 19 indexed citations

16.

Klena, John D., et al.. (2009). EnterotoxigenicEscherichia coliMultilocus Sequence Types in Guatemala and Mexico. Emerging infectious diseases. 16(1). 143–145. 12 indexed citations

17.

Taylor, David N., R. McKenzie, Anna P. Durbin, et al.. (2006). Rifaximin, a Nonabsorbed Oral Antibiotic, Prevents Shigellosis after Experimental Challenge. Clinical Infectious Diseases. 42(9). 1283–1288. 50 indexed citations

18.

Savarino, Stephen J. & A. Louis Bourgeois. (1993). Epidemiology of diarrhoeal diseases in developed countries. Transactions of the Royal Society of Tropical Medicine and Hygiene. 87. 7–11. 25 indexed citations

19.

Hyams, Kenneth C., A. Louis Bourgeois, B R Merrell, et al.. (1991). Diarrheal Disease during Operation Desert Shield. New England Journal of Medicine. 325(20). 1423–1428. 197 indexed citations

20.

Bourgeois, A. Louis, et al.. (1979). Penicillinase-producing Neisseria gonorrhoeae in a prepubertal female. The Journal of Pediatrics. 94(3). 431–432. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact